IEEE Foundation

VoxCell BioInnovation Inc.

VoxCell BioInnovation Inc.

linkedin-icon twitter-icon


VoxCell BioInnovation Inc. is developing human-like cancer tissue models as drug screening platforms.

These tissues are customized through innovative partnerships with pharmaceutical companies and CROs, focused on increasing the translation between the preclinical and clinical phases of drug development.

The tissue models are created by their proprietary technology: trade-secret vascularization software, Universal Bioink™, and a custom perfusion device.

The company is forging a new way forward in 3D bioprinting by creating human-like tissue models.

VoxCell BioInnovation Inc. became an IEEE Entrepreneurship Stars Recipient at Web Summit Rio 2024.